Prostate Cancer: Biology, Genetics, and the New Therapeutics
Progress in sequencing and characterizing the human genome has transformed cancer genetics both conceptually and methodologically. In Prostate Cancer: Biology, Genetics, and the New Therapeutics, leading cancer biologists and clinical researchers comprehensively review the latest basic research and...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2001
|
Schriftenreihe: | Contemporary Cancer Research
|
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | Progress in sequencing and characterizing the human genome has transformed cancer genetics both conceptually and methodologically. In Prostate Cancer: Biology, Genetics, and the New Therapeutics, leading cancer biologists and clinical researchers comprehensively review the latest basic research and its translational significance for the molecular biology and genetics of prostate cancer, as well as its application in developing novel therapeutics. Highlights of recent molecular genetics research include new light on inactivated tumor suppressor genes, HPC families, the role of the androgen receptor, the progression of prostate cancer, and promising results from transcriptome profiling and proteomics. Research into the basic biology and regulatory mechanisms controlling prostate cancer growth, progression, and stromal-epithelial interaction has revealed many new possibilities for therapeutic intervention, including cell adhesion molecules, the androgen receptor, use of the nuclear matrix, Caveolin-1, and the prostate-specific membrane antigen. Among the cancer therapeutic modalities discussed are chemoprevention, radiotherapy, radical retropubic prostatectomy, the development of dendritic-cell based vaccines, differentiation therapies, and gene therapy. Comprehensive and cutting-edge, Prostate Cancer: Biology, Genetics, and the New Therapeutics synthesizes all the major recent work that is not only rapidly unraveling the mysteries of prostate cancer, but also dramatically improving today's therapeutic approaches |
Beschreibung: | 1 Online-Ressource (XVIII, 531 p. 59 illus., 1 illus. in color) |
ISBN: | 9781592590094 |
DOI: | 10.1007/978-1-59259-009-4 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046145111 | ||
003 | DE-604 | ||
005 | 20210610 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2001 |||| o||u| ||||||eng d | ||
020 | |a 9781592590094 |9 978-1-59259-009-4 | ||
024 | 7 | |a 10.1007/978-1-59259-009-4 |2 doi | |
035 | |a (ZDB-2-SME)978-1-59259-009-4 | ||
035 | |a (OCoLC)1118998497 | ||
035 | |a (DE-599)BVBBV046145111 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.6 |2 23 | |
084 | |a XH 8000 |0 (DE-625)152949:13129 |2 rvk | ||
245 | 1 | 0 | |a Prostate Cancer |b Biology, Genetics, and the New Therapeutics |c edited by Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2001 | |
300 | |a 1 Online-Ressource (XVIII, 531 p. 59 illus., 1 illus. in color) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Contemporary Cancer Research | |
520 | |a Progress in sequencing and characterizing the human genome has transformed cancer genetics both conceptually and methodologically. In Prostate Cancer: Biology, Genetics, and the New Therapeutics, leading cancer biologists and clinical researchers comprehensively review the latest basic research and its translational significance for the molecular biology and genetics of prostate cancer, as well as its application in developing novel therapeutics. Highlights of recent molecular genetics research include new light on inactivated tumor suppressor genes, HPC families, the role of the androgen receptor, the progression of prostate cancer, and promising results from transcriptome profiling and proteomics. Research into the basic biology and regulatory mechanisms controlling prostate cancer growth, progression, and stromal-epithelial interaction has revealed many new possibilities for therapeutic intervention, including cell adhesion molecules, the androgen receptor, use of the nuclear matrix, Caveolin-1, and the prostate-specific membrane antigen. Among the cancer therapeutic modalities discussed are chemoprevention, radiotherapy, radical retropubic prostatectomy, the development of dendritic-cell based vaccines, differentiation therapies, and gene therapy. Comprehensive and cutting-edge, Prostate Cancer: Biology, Genetics, and the New Therapeutics synthesizes all the major recent work that is not only rapidly unraveling the mysteries of prostate cancer, but also dramatically improving today's therapeutic approaches | ||
650 | 4 | |a Urology | |
650 | 4 | |a Urology | |
650 | 0 | 7 | |a Prostatakrebs |0 (DE-588)4047511-6 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Prostatakrebs |0 (DE-588)4047511-6 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Chung, Leland W. K. |4 edt | |
700 | 1 | |a Isaacs, William B. |4 edt | |
700 | 1 | |a Simons, Jonathan W. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475763041 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475763034 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780896038684 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-59259-009-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031525296 | ||
966 | e | |u https://doi.org/10.1007/978-1-59259-009-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180481379401728 |
---|---|
any_adam_object | |
author2 | Chung, Leland W. K. Isaacs, William B. Simons, Jonathan W. |
author2_role | edt edt edt |
author2_variant | l w k c lwk lwkc w b i wb wbi j w s jw jws |
author_facet | Chung, Leland W. K. Isaacs, William B. Simons, Jonathan W. |
building | Verbundindex |
bvnumber | BV046145111 |
classification_rvk | XH 8000 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-59259-009-4 (OCoLC)1118998497 (DE-599)BVBBV046145111 |
dewey-full | 616.6 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.6 |
dewey-search | 616.6 |
dewey-sort | 3616.6 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-59259-009-4 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03348nmm a2200493zc 4500</leader><controlfield tag="001">BV046145111</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210610 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2001 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781592590094</subfield><subfield code="9">978-1-59259-009-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-59259-009-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-59259-009-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118998497</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145111</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8000</subfield><subfield code="0">(DE-625)152949:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prostate Cancer</subfield><subfield code="b">Biology, Genetics, and the New Therapeutics</subfield><subfield code="c">edited by Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVIII, 531 p. 59 illus., 1 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Contemporary Cancer Research</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Progress in sequencing and characterizing the human genome has transformed cancer genetics both conceptually and methodologically. In Prostate Cancer: Biology, Genetics, and the New Therapeutics, leading cancer biologists and clinical researchers comprehensively review the latest basic research and its translational significance for the molecular biology and genetics of prostate cancer, as well as its application in developing novel therapeutics. Highlights of recent molecular genetics research include new light on inactivated tumor suppressor genes, HPC families, the role of the androgen receptor, the progression of prostate cancer, and promising results from transcriptome profiling and proteomics. Research into the basic biology and regulatory mechanisms controlling prostate cancer growth, progression, and stromal-epithelial interaction has revealed many new possibilities for therapeutic intervention, including cell adhesion molecules, the androgen receptor, use of the nuclear matrix, Caveolin-1, and the prostate-specific membrane antigen. Among the cancer therapeutic modalities discussed are chemoprevention, radiotherapy, radical retropubic prostatectomy, the development of dendritic-cell based vaccines, differentiation therapies, and gene therapy. Comprehensive and cutting-edge, Prostate Cancer: Biology, Genetics, and the New Therapeutics synthesizes all the major recent work that is not only rapidly unraveling the mysteries of prostate cancer, but also dramatically improving today's therapeutic approaches</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chung, Leland W. K.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Isaacs, William B.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simons, Jonathan W.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475763041</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475763034</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780896038684</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-59259-009-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525296</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59259-009-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046145111 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:27Z |
institution | BVB |
isbn | 9781592590094 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525296 |
oclc_num | 1118998497 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XVIII, 531 p. 59 illus., 1 illus. in color) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2001 |
publishDateSearch | 2001 |
publishDateSort | 2001 |
publisher | Humana Press |
record_format | marc |
series2 | Contemporary Cancer Research |
spelling | Prostate Cancer Biology, Genetics, and the New Therapeutics edited by Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons Totowa, NJ Humana Press 2001 1 Online-Ressource (XVIII, 531 p. 59 illus., 1 illus. in color) txt rdacontent c rdamedia cr rdacarrier Contemporary Cancer Research Progress in sequencing and characterizing the human genome has transformed cancer genetics both conceptually and methodologically. In Prostate Cancer: Biology, Genetics, and the New Therapeutics, leading cancer biologists and clinical researchers comprehensively review the latest basic research and its translational significance for the molecular biology and genetics of prostate cancer, as well as its application in developing novel therapeutics. Highlights of recent molecular genetics research include new light on inactivated tumor suppressor genes, HPC families, the role of the androgen receptor, the progression of prostate cancer, and promising results from transcriptome profiling and proteomics. Research into the basic biology and regulatory mechanisms controlling prostate cancer growth, progression, and stromal-epithelial interaction has revealed many new possibilities for therapeutic intervention, including cell adhesion molecules, the androgen receptor, use of the nuclear matrix, Caveolin-1, and the prostate-specific membrane antigen. Among the cancer therapeutic modalities discussed are chemoprevention, radiotherapy, radical retropubic prostatectomy, the development of dendritic-cell based vaccines, differentiation therapies, and gene therapy. Comprehensive and cutting-edge, Prostate Cancer: Biology, Genetics, and the New Therapeutics synthesizes all the major recent work that is not only rapidly unraveling the mysteries of prostate cancer, but also dramatically improving today's therapeutic approaches Urology Prostatakrebs (DE-588)4047511-6 gnd rswk-swf Prostatakrebs (DE-588)4047511-6 s DE-604 Chung, Leland W. K. edt Isaacs, William B. edt Simons, Jonathan W. edt Erscheint auch als Druck-Ausgabe 9781475763041 Erscheint auch als Druck-Ausgabe 9781475763034 Erscheint auch als Druck-Ausgabe 9780896038684 https://doi.org/10.1007/978-1-59259-009-4 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Prostate Cancer Biology, Genetics, and the New Therapeutics Urology Prostatakrebs (DE-588)4047511-6 gnd |
subject_GND | (DE-588)4047511-6 |
title | Prostate Cancer Biology, Genetics, and the New Therapeutics |
title_auth | Prostate Cancer Biology, Genetics, and the New Therapeutics |
title_exact_search | Prostate Cancer Biology, Genetics, and the New Therapeutics |
title_full | Prostate Cancer Biology, Genetics, and the New Therapeutics edited by Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons |
title_fullStr | Prostate Cancer Biology, Genetics, and the New Therapeutics edited by Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons |
title_full_unstemmed | Prostate Cancer Biology, Genetics, and the New Therapeutics edited by Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons |
title_short | Prostate Cancer |
title_sort | prostate cancer biology genetics and the new therapeutics |
title_sub | Biology, Genetics, and the New Therapeutics |
topic | Urology Prostatakrebs (DE-588)4047511-6 gnd |
topic_facet | Urology Prostatakrebs |
url | https://doi.org/10.1007/978-1-59259-009-4 |
work_keys_str_mv | AT chunglelandwk prostatecancerbiologygeneticsandthenewtherapeutics AT isaacswilliamb prostatecancerbiologygeneticsandthenewtherapeutics AT simonsjonathanw prostatecancerbiologygeneticsandthenewtherapeutics |